NASDAQ : NKTR

Nektar Therapeutics — Financial statements

Healthcare · Biotechnology · United States

Last price 39.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.34B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Nektar Therapeutics (NKTR) reported revenue of 54.59M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue54.59M55.23M98.43M90.12M92.06M101.91M
Cost of Revenue30.69M33.77M21.64M24.90M
Gross Profit54.59M55.23M67.74M56.35M70.42M77.01M
Selling, General & Admin53.46M68.67M76.75M77.42M92.33M122.84M
Research & Development131.77M117.33M120.91M114.16M218.32M400.27M
Operating Expenses185.23M186.00M197.66M191.58M310.66M523.11M
Operating Income-130.64M-130.77M-129.92M-135.22M-240.24M-446.10M
Interest Expense-30.96M-26.18M-28.11M-25.33M-28.91M-47.31M
Interest & Investment Income19.18M10.44M14.50M19.01M6.78M2.73M
Earnings From Equity Investments-3.95M-8.73M
Other Non Operating Income (Expenses)-601.00K361.00K-390.00K-1.15M33.31M-8.19M
EBT Excluding Unusual Items-146.97M-154.88M-143.92M-142.70M-229.05M-498.87M
Merger & Restructuring Charges-10.09M-9.33M-15.67M-51.96M-135.93M
Impairment of Goodwill-76.50M
Gain (Loss) on Sale of Assets40.39M-5.10M
Other Unusual Items-24.41M
Pretax Income-157.06M-164.21M-119.20M-276.26M-364.98M-523.28M
Income Tax Expense64.00K-138.00K-239.00K-200.00K3.21M557.00K
Net Income-157.13M-164.08M-118.96M-276.06M-368.20M-523.84M
Net Income to Common-157.13M-164.08M-118.96M-276.06M-368.20M-523.84M
Shares Outstanding (Basic)24.29M16.87M13.71M12.67M12.48M12.22M
Shares Outstanding (Diluted)24.29M16.87M13.71M12.67M12.48M12.22M
EPS (Basic)-6.47-9.73-8.68-21.79-29.51-42.87
EPS (Diluted)-6.47-9.73-8.68-21.79-29.55-42.90
Free Cash Flow-234.73M-209.38M-177.18M-193.47M-309.68M-427.65M
Free Cash Flow Per Share-9.66-12.41-12.92-15.27-24.82-35.00
Gross Margin100.00%100.00%68.82%62.53%76.50%75.57%
Operating Margin-239.32%-236.77%-131.99%-150.05%-260.97%-437.76%
Profit Margin-287.84%-297.07%-120.86%-306.31%-399.98%-514.03%
Free Cash Flow Margin-429.99%-379.09%-180.01%-214.68%-336.41%-419.65%
EBITDA-129.95M-129.75M-125.53M-127.41M-227.21M-431.96M
EBITDA Margin-238.05%-234.91%-127.53%-141.38%-246.81%
D&A For EBITDA693.00K1.03M4.39M7.82M13.03M14.15M
EBIT-130.64M-130.77M-129.92M-135.22M-240.24M-446.10M
EBIT Margin-239.32%-236.77%-131.99%-150.05%-260.97%
Revenue as Reported54.59M55.23M98.43M90.12M92.06M101.91M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents39.27M15.12M44.25M35.28M88.23M25.22M
Short-Term Investments645.07M230.64M210.97M268.34M416.75M708.74M
Cash & Short-Term Investments684.34M245.75M255.23M303.62M504.98M733.96M
Accounts Receivable1.21M5.98M22.49M
Other Receivables4.76M1.78M1.61M1.05M2.42M1.40M
Receivables4.76M1.78M1.61M2.25M8.40M23.89M
Inventory16.10M19.20M15.80M
Prepaid Expenses2.15M2.19M2.51M4.41M5.99M
Other Current Assets48.15M16.54M1.95M4.33M7.40M21.93M
Total Current Assets739.40M266.27M261.29M330.70M545.97M795.58M
Property, Plant & Equipment5.00M11.82M36.86M85.89M177.53M
Long-Term Investments339.06M3.49M26.09M25.82M64.83M
Goodwill76.50M76.50M
Other Long-Term Assets16.67M5.65M4.65M4.64M2.25M2.74M
Total Assets1.10B280.41M303.85M398.03M710.60M1.12B
Accounts Payable24.89M10.77M11.56M9.85M12.98M9.75M
Accrued Expenses19.88M19.64M27.20M19.14M28.85M58.01M
Current Portion of Leases22.71M20.50M19.87M19.26M18.67M17.44M
Other Current Liabilities3.50M2.63M2.77M3.02M7.71M
Total Current Liabilities70.98M53.54M61.40M51.27M68.20M85.20M
Long-Term Debt57.38M63.16M91.78M112.62M155.38M195.43M
Long-Term Leases55.85M65.26M82.70M98.52M112.83M125.74M
Other Long-Term Liabilities7.79M8.62M7.24M4.63M7.55M31.32M
Total Liabilities192.01M190.57M243.11M267.05M343.96M437.68M
Common Stock3.00K2.00K1.00K19.00K19.00K19.00K
Additional Paid-In Capital4.75B3.85B3.66B3.61B3.57B3.52B
Retained Earnings-3.85B-3.76B-3.60B-3.48B-3.20B-2.83B
Treasury Stock-3.00M
Comprehensive Income & Other-1.76M17.00K61.00K80.00K-6.91M-4.16M
Shareholders' Equity903.12M89.83M60.74M130.99M366.64M679.51M
Total Liabilities & Equity1.10B280.41M303.85M398.03M710.60M1.12B
Total Debt135.93M148.91M194.34M230.40M286.87M338.60M
Net Cash (Debt)548.41M96.84M74.75M99.04M218.10M460.18M
Net Cash Per Share22.575.745.457.8217.4837.66
Filing Date Shares Outstanding34.14M28.69M12.41M12.24M12.62M12.42M
Total Common Shares Outstanding34.13M20.38M12.39M12.76M12.57M12.36M
Working Capital668.42M212.73M199.89M279.43M477.76M710.38M
Book Value Per Share26.464.414.9010.2729.1754.96
Tangible Book Value903.12M89.83M60.74M130.99M290.14M603.01M
Tangible Book Value Per Share26.464.414.9010.2723.0848.77
Buildings43.18M74.89M97.39M
Machinery61.83M79.76M104.00M
Construction In Progress739.00K2.53M7.16M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-157.13M-164.08M-118.96M-276.06M-368.20M-523.84M
Depreciation & Amortization693.00K1.03M4.39M7.82M13.03M14.15M
Loss (Gain) From Sale of Assets-40.39M1.30M-3.33M
Asset Writedown & Restructuring Costs4.44M4.44M8.33M111.83M70.71M16.70M
Loss (Gain) on Equity Investments3.95M8.73M
Stock-Based Compensation11.98M12.65M21.61M33.39M57.32M94.67M
Other Operating Activities-31.88M-34.26M-44.45M-50.94M-74.04M8.63M
Change in Accounts Receivable-3.04M4.78M16.51M12.40M
Change in Inventory497.00K699.00K-3.40M-509.00K
Change in Accounts Payable10.61M-625.00K2.67M-2.88M3.10M-11.69M
Change in Other Net Operating Assets-76.46M-36.39M-6.36M-22.53M-15.72M-23.17M
Operating Cash Flow-233.79M-208.51M-175.71M-192.61M-304.01M-412.66M
Capital Expenditures-941.00K-868.00K-1.47M-865.00K-5.68M-14.99M
Sale of Property, Plant & Equipment1.25M13.20M
Investment in Securities-844.16M-329.00K78.65M139.18M358.31M217.77M
Other Investing Activities697.00K65.39M
Investing Cash Flow-844.40M-1.20M142.57M139.56M365.83M202.78M
Long-Term Debt Issued180.85M
Net Debt Issued (Repaid)287.55M180.85M
Issuance of Common Stock5.58M866.00K118.00K30.00K758.00K33.24M
Repurchase of Common Stock-3.00M
Other Financing Activities781.34M-1.15M45.00M750.00K3.00M
Financing Cash Flow1.07B180.57M42.12M30.00K1.51M36.24M
Foreign Exchange Rate Adjustments1.00K6.00K-4.00K62.00K-327.00K-92.00K
Net Cash Flow-3.72M-29.14M8.97M-52.95M63.01M-173.74M
Free Cash Flow-234.73M-209.38M-177.18M-193.47M-309.68M-427.65M
Free Cash Flow Margin-429.99%-379.09%-180.01%-214.68%-336.41%-419.65%
Free Cash Flow Per Share-9.66-12.41-12.92-15.27-24.82-35.00
Levered Free Cash Flow-134.77M-108.23M-43.69M-63.63M-101.13M-234.18M
Unlevered Free Cash Flow-115.41M-91.86M-26.12M-47.80M-83.06M-204.61M
Cash Income Tax Paid-195.00K76.00K2.66M272.00K325.00K
Change in Working Capital-65.85M-37.02M-6.24M-19.94M492.00K-22.97M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.33B860.04M171.55M107.79M424.78M2.49B
Enterprise Value783.17M756.91M128.61M-19.97M178.64M1.87B
Last Close Price38.8742.2813.958.4733.90202.65
Forward PE15.8815.8815.8815.8815.88
PS Ratio24.3115.571.741.204.6124.47
PB Ratio1.479.572.820.821.163.67
P/TBV Ratio1.479.572.820.821.464.13
EV/Sales Ratio14.2713.701.311.9418.31
Debt / Equity Ratio0.151.663.201.760.780.50
Net Debt / Equity Ratio-0.61-1.08-1.23-0.76-0.59-0.68
Net Debt / EBITDA Ratio4.220.750.600.780.961.06
Net Debt / FCF Ratio2.340.460.420.510.701.08
Asset Turnover0.080.190.280.160.100.08
Inventory Turnover1.911.241.60
Quick Ratio9.714.624.185.977.538.89
Current Ratio10.424.974.266.458.019.34
Return on Equity (ROE)-35.75%-217.94%-124.10%-110.95%-70.39%-59.64%
Return on Assets (ROA)-12.54%-27.98%-23.14%-15.25%-16.43%-21.00%
Return on Invested Capital (ROIC)-51.66%-131.09%-111.04%-137.22%
Return on Capital Employed (ROCE)-12.80%-57.60%-53.60%-39.00%-37.40%-43.20%
Earnings Yield-16.58%-19.08%-69.35%-256.12%-86.68%-21.01%
FCF Yield-17.69%-24.34%-103.28%-179.50%-72.91%-17.15%
Buyback Yield / Dilution-73.25%-23.05%-8.24%-1.53%-2.10%-2.64%